European Archives - Page 525 of 1054 - European Medical Journal

Screening for Lung Cancer with Low-Dose Spiral CT: An Updated Review

IN 2020, lung cancer was the second most common cancer and the leading cause of death from cancer among both males and females in the USA. Screening…

Correlation Between COVID-19 Lung Severity and Neurologic Symptoms

CORONAVIRUS disease (COVID-19) has been linked to the development of neurological symptoms and complications in patients who become ill with the…

EMJ Cardiology 9 [Supplement 2] 2021 feature image

Novel Insights into Cardiac Biomarkers in Atrial Fibrillation, Heart Failure, and Coronary Heart Disease | Advancing Understanding and Clinical Application of Cardiac Biomarkers

Oral anticoagulation is currently underused in AF management, with one-third of cases remaining silent and asymptomatic. The STROKESTOP…

EMJ Cardiology 9 [Supplement 2] 2021 feature image

EMJ Cardiology 9 [Supplement 2] 2021

The proCardio event, a global Cardiac Biomarker Forum, was held virtually as a series of three webinars from 12th to 14th October 2020…

Can Machine Learning Accurately Identify Malignant Blood Disorders?

YELODYSPLASTIC syndrome (MDS) is a disorder that disrupts the maturation and differentiation of haematopoietic stem cells in the bone marrow.

Infographic: Brain–Computer Interfaces

A brain–computer interface (BCI) measures, analyses, and translates the activity of the central nervous system (CNS) into artificial…

Talking to Rob Jekielek

Rob Jekielek, Managing Director, The Harris Poll, discusses the evolving public perceptions of the pharma industry.

Chondroprotection: What, When, and Why?

Investigating osteoarthritis (OA), a long-term chronic disease that is increasing year on year due to population ageing and growth in related factors such as obesity.

EMJ 6.1 Feature Image

EMJ 6.1 2021

EMJ 6.1 brings together peer-reviewed research articles sharing topical advancements across a range of therapeutic disciplines, including cardiology, gastroenterology, microbiology, and more. These are accompanied by exciting features as well as interviews with world-class experts in dermatology and oncology, making this an issue that will cater to every clinician.

Emerging Treatments for Crohn's Disease cover image

Emerging Treatments for Crohn's Disease: Cells, Surgery, and Novel Therapeutics

Despite the development of multiple biological therapies for Crohn’s disease (CD), remission rates at 1 year from individual agents are still only 30–50%…